vs
HAWKINS INC（HWKN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
HAWKINS INC的季度营收约是REPLIGEN CORP的1.2倍（$244.1M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 5.9%，领先0.8%），REPLIGEN CORP同比增速更快（13.6% vs 7.9%），HAWKINS INC自由现金流更多（$21.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 8.2%）
霍金斯公司是印度知名厨具制造商，总部位于孟买，在塔那、霍希亚布尔、 jaunpur设有三座生产基地，旗下拥有Hawkins、Futura、Contura等多个品牌，主营压力锅及各类炊具产品，是印度规模最大的压力锅生产商之一，产品出口至全球超65个国家和地区。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HWKN vs RGEN — 直观对比
营收规模更大
HWKN
是对方的1.2倍
$197.9M
营收增速更快
RGEN
高出5.7%
7.9%
净利率更高
RGEN
高出0.8%
5.9%
自由现金流更多
HWKN
多$3.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
8.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $244.1M | $197.9M |
| 净利润 | $14.3M | $13.3M |
| 毛利率 | 20.8% | 52.5% |
| 营业利润率 | 9.2% | 9.0% |
| 净利率 | 5.9% | 6.7% |
| 营收同比 | 7.9% | 13.6% |
| 净利润同比 | -4.7% | 143.9% |
| 每股收益（稀释后） | $0.69 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HWKNRGEN
| Q4 25 | $244.1M | $197.9M | ||
| Q3 25 | $280.4M | $188.8M | ||
| Q2 25 | $293.3M | $182.4M | ||
| Q1 25 | $245.3M | $169.2M | ||
| Q4 24 | $226.2M | $174.1M | ||
| Q3 24 | $247.0M | $154.9M | ||
| Q2 24 | $255.9M | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润HWKNRGEN
| Q4 25 | $14.3M | $13.3M | ||
| Q3 25 | $22.6M | $14.9M | ||
| Q2 25 | $29.2M | $14.9M | ||
| Q1 25 | $16.3M | $5.8M | ||
| Q4 24 | $15.0M | $-30.3M | ||
| Q3 24 | $24.1M | $-654.0K | ||
| Q2 24 | $28.9M | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率HWKNRGEN
| Q4 25 | 20.8% | 52.5% | ||
| Q3 25 | 24.1% | 53.2% | ||
| Q2 25 | 24.7% | 50.0% | ||
| Q1 25 | 21.3% | 53.6% | ||
| Q4 24 | 21.4% | 26.1% | ||
| Q3 24 | 24.4% | 50.0% | ||
| Q2 24 | 25.3% | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率HWKNRGEN
| Q4 25 | 9.2% | 9.0% | ||
| Q3 25 | 12.1% | 8.9% | ||
| Q2 25 | 14.1% | 7.6% | ||
| Q1 25 | 10.0% | 3.9% | ||
| Q4 24 | 9.3% | -17.7% | ||
| Q3 24 | 13.7% | -5.1% | ||
| Q2 24 | 15.6% | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率HWKNRGEN
| Q4 25 | 5.9% | 6.7% | ||
| Q3 25 | 8.1% | 7.9% | ||
| Q2 25 | 9.9% | 8.2% | ||
| Q1 25 | 6.7% | 3.4% | ||
| Q4 24 | 6.6% | -17.4% | ||
| Q3 24 | 9.8% | -0.4% | ||
| Q2 24 | 11.3% | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益（稀释后）HWKNRGEN
| Q4 25 | $0.69 | $0.24 | ||
| Q3 25 | $1.08 | $0.26 | ||
| Q2 25 | $1.40 | $0.26 | ||
| Q1 25 | $0.77 | $0.10 | ||
| Q4 24 | $0.72 | $-0.55 | ||
| Q3 24 | $1.16 | $-0.01 | ||
| Q2 24 | $1.38 | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $264.0M | $542.2M |
| 股东权益账面价值 | $518.9M | $2.1B |
| 总资产 | $976.5M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.51× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HWKNRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | $5.1M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务HWKNRGEN
| Q4 25 | $264.0M | $542.2M | ||
| Q3 25 | $279.0M | $537.9M | ||
| Q2 25 | $299.0M | — | ||
| Q1 25 | $149.0M | — | ||
| Q4 24 | $114.0M | $525.6M | ||
| Q3 24 | $104.0M | — | ||
| Q2 24 | $134.0M | — | ||
| Q1 24 | — | — |
股东权益HWKNRGEN
| Q4 25 | $518.9M | $2.1B | ||
| Q3 25 | $507.0M | $2.1B | ||
| Q2 25 | $484.6M | $2.1B | ||
| Q1 25 | $460.3M | $2.0B | ||
| Q4 24 | $457.0M | $2.0B | ||
| Q3 24 | $443.4M | $2.0B | ||
| Q2 24 | $421.2M | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产HWKNRGEN
| Q4 25 | $976.5M | $2.9B | ||
| Q3 25 | $984.2M | $2.9B | ||
| Q2 25 | $988.3M | $2.9B | ||
| Q1 25 | $769.9M | $2.9B | ||
| Q4 24 | $707.2M | $2.8B | ||
| Q3 24 | $689.7M | $2.8B | ||
| Q2 24 | $702.7M | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比HWKNRGEN
| Q4 25 | 0.51× | 0.26× | ||
| Q3 25 | 0.55× | 0.26× | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.25× | 0.27× | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $21.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 8.7% | 8.9% |
| 资本支出强度资本支出/营收 | 5.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.48× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $87.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流HWKNRGEN
| Q4 25 | $35.6M | $25.7M | ||
| Q3 25 | $39.5M | $48.1M | ||
| Q2 25 | $31.5M | $28.6M | ||
| Q1 25 | $30.8M | $15.0M | ||
| Q4 24 | $21.0M | $39.2M | ||
| Q3 24 | $41.6M | $49.3M | ||
| Q2 24 | $17.6M | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流HWKNRGEN
| Q4 25 | $21.2M | $17.6M | ||
| Q3 25 | $28.7M | $43.4M | ||
| Q2 25 | $17.9M | $21.5M | ||
| Q1 25 | $19.8M | $11.4M | ||
| Q4 24 | $12.3M | $33.6M | ||
| Q3 24 | $31.0M | $42.3M | ||
| Q2 24 | $6.9M | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率HWKNRGEN
| Q4 25 | 8.7% | 8.9% | ||
| Q3 25 | 10.2% | 23.0% | ||
| Q2 25 | 6.1% | 11.8% | ||
| Q1 25 | 8.1% | 6.8% | ||
| Q4 24 | 5.4% | 19.3% | ||
| Q3 24 | 12.5% | 27.3% | ||
| Q2 24 | 2.7% | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度HWKNRGEN
| Q4 25 | 5.9% | 4.1% | ||
| Q3 25 | 3.9% | 2.5% | ||
| Q2 25 | 4.6% | 3.9% | ||
| Q1 25 | 4.5% | 2.1% | ||
| Q4 24 | 3.9% | 3.2% | ||
| Q3 24 | 4.3% | 4.5% | ||
| Q2 24 | 4.2% | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率HWKNRGEN
| Q4 25 | 2.48× | 1.93× | ||
| Q3 25 | 1.75× | 3.23× | ||
| Q2 25 | 1.08× | 1.92× | ||
| Q1 25 | 1.89× | 2.57× | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | 0.61× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HWKN
| Manufactured Blended Or Repackaged Products | $107.0M | 44% |
| Industrial Solutions | $53.6M | 22% |
| Food | $29.2M | 12% |
| Nutrition | $24.6M | 10% |
| Bulk Products | $12.0M | 5% |
| Water Surplus Inc. | $8.4M | 3% |
| Pharmaceutical | $7.3M | 3% |
| Other | $1.5M | 1% |
RGEN
暂无分部数据
